Home The Word Brain	My Amedeo FAQ Privacy About
	C49 + CC Journal Club For more information, please refer to our special emails from April 13 and May 19.

Malaria

Free Subscription Articles published in Lancet Retrieve available abstracts of 32 articles: HTML format

Single Articles

March 2025
1. LACERDA MVG, Bassat Q
   Mapping the malaria burden in the context of a global pandemic: progress, hiccups, and challenges.
   Lancet. 2025 Mar 5:S0140-6736(25)00418-0. doi: 10.1016/S0140-6736(25)00418.
   PubMed    
   
   
   
2. WEISS DJ, Dzianach PA, Saddler A, Lubinda J, et al
   Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum and Plasmodium vivax malaria, 2000-22: a spatial and temporal modelling study.
   Lancet. 2025 Mar 5:S0140-6736(25)00038-8. doi: 10.1016/S0140-6736(25)00038.
   PubMed     Abstract available
   
   
   February 2025
3. KIRBY T
   Marcus Lacerda: aiming to eliminate vivax malaria.
   Lancet. 2025;405:456.
   PubMed    
   
   
   January 2025
4. DATOO MS, Hill AVS, Beaumont E, Bradley J, et al
   The R21/Matrix-M malaria vaccine: questions remain - Author's reply.
   Lancet. 2025;405:299-301.
   PubMed    
   
   
   
5. AABY P, Bjorkman A, Schapira A, Benn CS, et al
   The R21/Matrix-M malaria vaccine: questions remain.
   Lancet. 2025;405:299.
   PubMed    
   
   
   
6. OBARO S, Mokuolu O, Michelow IC
   The R21/Matrix-M malaria vaccine: questions remain.
   Lancet. 2025;405:299.
   PubMed    
   
   
   
7. LI Y, Liu G
   The R21/Matrix-M malaria vaccine: questions remain.
   Lancet. 2025;405:298-299.
   PubMed    
   
   
   
8. GONCALVES MADA, Morais H, Ribeiro Junior HL
   Malaria and undernutrition in Angola.
   Lancet. 2025;405:296-297.
   PubMed    
   
   
   
9. IMPOUMA B, Adidja A, Mboussou F, Cabore J, et al
   Malaria vaccine introduction in Africa: progress and challenges.
   Lancet. 2025 Jan 21:S0140-6736(24)02841-1. doi: 10.1016/S0140-6736(24)02841.
   PubMed    
   
   
   December 2024
10. OCHOMO EO, Gimnig JE, Awori Q, Abong'o B, et al
    Effect of a spatial repellent on malaria incidence in an area of western Kenya characterised by high malaria transmission, insecticide resistance, and universal coverage of insecticide treated nets (part of the AEGIS Consortium): a cluster-randomised,
    Lancet. 2024 Dec 19:S0140-6736(24)02253-0. doi: 10.1016/S0140-6736(24)02253.
    PubMed     Abstract available
    
    
    
11. SWAI JK, Moore SJ
    Beyond repellents: spatial emanators for the control of malaria in Africa.
    Lancet. 2024 Dec 19:S0140-6736(24)02754-5. doi: 10.1016/S0140-6736(24)02754.
    PubMed    
    
    
    April 2024
12. ASANTE KP, Mathanga DP, Milligan P, Akech S, et al
    Feasibility, safety, and impact of the RTS,S/AS01(E) malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi.
    Lancet. 2024 Apr 4:S0140-6736(24)00004-7. doi: 10.1016/S0140-6736(24)00004.
    PubMed     Abstract available
    
    
    
13. DAUBENBERGER CA, Silva JC
    First-generation malaria vaccine successfully implemented in three African countries.
    Lancet. 2024 Apr 4:S0140-6736(23)02892-1. doi: 10.1016/S0140-6736(23)02892.
    PubMed    
    
    
    February 2024
14. THE LANCET
    Malaria vaccines: a test for global health.
    Lancet. 2024;403:503.
    PubMed    
    
    
    
15. ADEPOJU P
    Routine malaria vaccinations begin.
    Lancet. 2024;403:423.
    PubMed    
    
    
    
16. MOORTHY V, Hamel MJ, Smith PG
    Malaria vaccines for children: and now there are two.
    Lancet. 2024 Feb 1:S0140-6736(23)02743-5. doi: 10.1016/S0140-6736(23)02743.
    PubMed    
    
    
    
17. DATOO MS, Dicko A, Tinto H, Ouedraogo JB, et al
    Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.
    Lancet. 2024 Feb 1:S0140-6736(23)02511-4. doi: 10.1016/S0140-6736(23)02511.
    PubMed     Abstract available
    
    
    January 2024
18. NAKWEYA G
    Cabo Verde eliminates malaria.
    Lancet. 2024;403:341.
    PubMed    
    
    
    
19. KAMYA MR, Kakuru A, Dorsey G
    Dihydroartemisinin-piperaquine for prevention of malaria in pregnant women living with HIV.
    Lancet. 2024 Jan 12:S0140-6736(24)00048-5. doi: 10.1016/S0140-6736(24)00048.
    PubMed    
    
    
    
20. BARSOSIO HC, Madanitsa M, Ondieki ED, Dodd J, et al
    Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial.
    Lancet. 2024 Jan 12:S0140-6736(23)02631-4. doi: 10.1016/S0140-6736(23)02631.
    PubMed     Abstract available
    
    
    November 2023
21. ASSEFA A, Parr JB
    Universal radical cure: prospects and challenges for malaria elimination.
    Lancet. 2023 Nov 15:S0140-6736(23)01950-5. doi: 10.1016/S0140-6736(23)01950.
    PubMed    
    
    
    
22. THRIEMER K, Degaga TS, Christian M, Alam MS, et al
    Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial.
    Lancet. 2023 Nov 15:S0140-6736(23)01553-2. doi: 10.1016/S0140-6736(23)01553.
    PubMed     Abstract available
    
    
    
23. POESPOPRODJO JR, Douglas NM, Ansong D, Kho S, et al
    Malaria.
    Lancet. 2023 Nov 1:S0140-6736(23)01249-7. doi: 10.1016/S0140-6736(23)01249.
    PubMed     Abstract available
    
    
    October 2023
24. ADEPOJU P
    Malaria community welcomes WHO vaccine approval.
    Lancet. 2023;402:1316.
    PubMed    
    
    
    September 2023
25. KESSY SA, Tibenderana JR
    Zanzibar's malaria elimination efforts: progress, challenges, and lessons.
    Lancet. 2023;402:774.
    PubMed    
    
    
    
26. HAWLEY WA, Laihad FJ, Ochomo E, Achee NL, et al
    What constitutes high-quality evidence for malaria vector control?
    Lancet. 2023;402:773-774.
    PubMed    
    
    
    July 2023
27. SAMARASEKERA U
    Climate change and malaria: predictions becoming reality.
    Lancet. 2023;402:361-362.
    PubMed    
    
    
    
28. DEVI S
    12 countries to get first doses of malaria vaccine.
    Lancet. 2023;402:172.
    PubMed    
    
    
    May 2023
29. ZAROCOSTAS J
    Gavi unveils malaria vaccine plans.
    Lancet. 2023;401:1485.
    PubMed    
    
    
    April 2023
30. KEATING C
    Artesunate versus quinine: the controlled trials watershed.
    Lancet. 2023;401:1329-1331.
    PubMed    
    
    
    
31. PASRICHA SR, Mwangi MN, Moya E, Ataide R, et al
    Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial.
    Lancet. 2023 Apr 20:S0140-6736(23)00278-7. doi: 10.1016/S0140-6736(23)00278.
    PubMed     Abstract available
    
    
    March 2023
32. KAKURU A, Jagannathan P
    Can we reduce malaria in pregnancy and improve birth outcomes?
    Lancet. 2023 Mar 10:S0140-6736(23)00101-0. doi: 10.1016/S0140-6736(23)00101.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malaria is free of charge.